Riskpilot← Back to searchSign inGet full accessNIOX AB
ABActiveOrg 5565491056Hansellisgatan 13Research and experimental development on natural sciences and engineering · NACE 7210Est. 199714 employees
Revenue 2024
SEK 419,6M
+15% vs 2023
EBITDA margin
53.9%
+16% vs 2023
Equity ratio
78.8%
Financial strength
Net profit 2024
SEK 228,3M
-23% vs 2023
| Revenue | SEK 419,6M | +15% |
| EBITDA | SEK 226,3M | +16% |
| Net profit | SEK 228,3M | -23% |
| Total assets | SEK 1,4B | +23% |
| Equity | SEK 1,1B | +26% |
| Employees | 14 | — |
Legal name
NIOX AB
Org number
5565491056
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24 november 1997
Share capital
SEK 349 422 000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva utveckling, tillverkning och försäljning av utrustning och preparat för medicinsk diagnostik samt annan därmed förenlig verksamhet.
Address
Hansellisgatan 13
Email
info@aerocrine.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 209 101 | 243 000 | 287 363 | 363 677 | 419 591 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 90 076 | 120 000 | −1 748 | 195 223 | 226 304 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 90 076 | 120 000 | −1 748 | 195 223 | 226 304 |
| Net financials | 5 501 | 6 000 | 19 300 | 30 506 | 60 274 |
| Profit before tax | 95 577 | 125 000 | 17 552 | 225 729 | 286 578 |
| Tax | −98 996 | 52 000 | 45 558 | 72 337 | −58 288 |
| Net profit | −3 419 | 177 000 | 63 110 | 298 066 | 228 290 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 527 248 | 724 000 | 826 478 | 1 143 972 | 1 409 771 |
| Equity | 341 322 | 519 000 | 582 213 | 880 956 | 1 110 801 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 185 831 | 205 000 | 244 105 | 262 816 | 298 520 |
| Total debt | 185 831 | 205 000 | 244 105 | 262 816 | 298 520 |
EBITDA margin
53.9%
This company
15.8%
Market median
+241% vs market
20202024
Equity ratio
78.8%
This company
38.2%
Market median
+106% vs market
20202024
Return on equity
20.6%
This company
18.4%
Market median
+12% vs market
20202024
Net profit margin
54.4%
This company
8.1%
Market median
+572% vs market
20202024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20202024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PO Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
KH Chief Auditor | Chief Auditor | 2022 – 2025 |
KL Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Chairman | 2025 | |
| Board of Directors | 2020 | |
| Former (7) | ||
| Board of Directors | 2020 – 2020 | |
| Chairman | 2020 – 2020 | |
| Chairman | 2022 – 2025 | |
| Deputy Board Member | 2020 – 2025 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2020 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NIOX HEALTHCARE LTD
NIOX AB (this company)Niox GmbhCircassia SrlNIOX GMBHCircassia GmbhBoard members of NIOX AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Henrik Ehrenpohl | Chief Auditor | 0 companies |
| Per-Johan Olov Elert | Chief Auditor | 0 companies |
| Karl Leonard Daun | Chief Auditor | 0 companies |
| Per Rikard Wikström | Deputy Board Member | 0 companies |
| David Richard Williams | Board of Directors | 0 companies |
| Sarah Elizabeth Duncan | Chairman | 0 companies |
| Jan Lundquist | Board of Directors | 0 companies |
| Steven Charles Andrew Harris | Chairman | 0 companies |
| Michael Roy David Roller | Chairman | 0 companies |
| Per Rolf Oscar Mattsson | Deputy Board Member | 0 companies |
| Rebecca Mary Clayton | Board of Directors | 0 companies |
| Julien Fabrice Cotta | Board of Directors | 0 companies |
| Ian Roy Johnson | Chairman | 0 companies |